“…The safety profile is therefore well established in many different patient groups, including CKD, GI disorders, women’s health disorders, oncology, cardiology, and for patient blood management (Tables 2 , 3 , 4 , 5 , 6 , 7 ). To date, more than 50 published clinical studies, covering numerous patient populations, have reported safety outcomes with administration of iron sucrose; 18 of these studies have been reported in the last 5 years [ 40 , 46 , 47 , 50 , 52 , 53 , 58 , 66 , 73 , 74 , 111 , 113 , 114 , 126 , 127 , 129 – 131 ].…”